Notice of interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 13.5.2022Glenmark Pharmaceuticals s.r.o. (GLM-CZ)5183BPreglenix 75 mg tvrdé kapsuly (cps dur 56x75 mg (blis.PVC/Al))1.5.2023Z
 1.6.2021UCB s.r.o. (UCB-CZ-2)32720Xyzal (tbl flm 50x5 mg (blis.Al/OPA/Al/PVC))1.9.2022R
 2.5.2022Janssen - Cilag International N.V. (JNS)40531VELCADE 3,5 mg prášok na injekčný roztok (plv ino 1x3,5 mg (liek.inj.skl.))31.8.2022Z
 13.5.2022Glenmark Pharmaceuticals s.r.o. (GLM-CZ)5191BPreglenix 150 mg tvrdé kapsuly (cps dur 56x150 mg (blis.PVC/Al))1.8.2022Z
 16.5.2022INN-FARM d.o.o. (IAR)7903ACefixime InnFarm 400 mg (tbl flm 10x400 mg (bli.PVC/PVDC/Al))31.7.2022R
 11.1.2022UCB s.r.o. (UCB-CZ-2)32720Xyzal (tbl flm 50x5 mg (blis.Al/OPA/Al/PVC))1.7.2022Z
 21.4.2022Teva B.V. (TEV-NL-4)2280DEzetimib/simvastatín Teva B.V. 10 mg/40 mg (tbl 98x10 mg/40 mg (blis.OPA/Al/PVC/Al))15.6.2022Z
 13.5.2022KRKA, d.d., Novo mesto (KRK-2)50075Cezera 5 mg (tbl flm 30x5 mg (bli. PVC/PVDC/Al))6.6.2022R
 20.4.2022KRKA, d.d., Novo mesto (KRK-2)0961BSobycombi 5 mg/5 mg tablety (tbl 90x5 mg/5 mg (blis.OPA/Al/PVC/Al))6.6.2022R
 25.2.2022Actavis Group PTC ehf. (ACT-5)9043ACleosensa 0,03 mg/3 mg (tbl flm 3x21 (blis.PVC/PVDC/Al))1.6.2022Z
 8.4.2022UCB s.r.o. (UCB-CZ-2)32720Xyzal (tbl flm 50x5 mg (blis.Al/OPA/Al/PVC))1.6.2022Z
 13.5.2022Pfizer Europe MA EEIG (PFI-BE-3)60387DALACIN T 1 % dermálna emulzia (emu der 1x30 ml (fľ.PE))1.6.2022R
 23.3.2022STADA Arzneimittel AG (STD)45784ENELBIN 100 retard (tbl plg 100x100 mg (blis.PVC/Al))1.6.2022R
 25.2.2022Teva B.V. (TEV-NL-4)8472CAprepitant Teva 80 mg a Aprepitant Teva 125 mg (cps dur 1x125 mg+2x80 mg (blis.Al/OPA/Al/PVC))1.6.2022Z
 4.1.2022Biologische Heilmittel Heel GmbH (HEE)27356Klimakt-Heel (tbl 50 (liek.plast.))1.6.2022Z

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To